Catalio Capital Management, LP
Source: SEC Form 13F · as of Mar 2026Catalio Capital Management, LP holds 20 biotech & pharma companies tracked by BioSniper, totaling $266.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$266.7M
BioSniper AIPage context preserved
Prepared research question
What matters most for Dianthus Therapeutics, Inc. /DE/ (DNTH)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| DNTHDianthus Therapeutics, Inc. /DE/ | 560,308 | $47.0M |
| BBIOBridgeBio Pharma, Inc. | 432,014 | $32.1M |
| GILDGILEAD SCIENCES, INC. | 163,905 | $22.8M |
| TERNTerns Pharmaceuticals, Inc. | 409,031 | $21.6M |
| DFTXDefinium Therapeutics Inc. | 1,037,984 | $19.6M |
| SLNOSOLENO THERAPEUTICS INC | 577,808 | $19.3M |
| INCYIncyte Corp. | 182,101 | $17.1M |
| CYTKCYTOKINETICS INC | 215,501 | $14.2M |
| GPCRStructure Therapeutics Inc. | 255,379 | $12.3M |
| MANEVeradermics Incorporated | 173,582 | $11.0M |
| ADPTAdaptive Biotechnologies Corp | 722,784 | $10.0M |
| KALVKalVista Pharmaceuticals, Inc. | 426,551 | $8.6M |
| QUREuniQure N.V. | 491,116 | $8.0M |
| IRONDisc Medicine, Inc. | 122,978 | $7.9M |
| ABVXAbivax SA | 47,193 | $5.3M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 62,019 | $3.2M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 83,554 | $2.7M |
| IMCRImmunocore Holdings plc | 84,352 | $2.5M |
| MGXMetagenomi Therapeutics, Inc. | 528,993 | $709K |
| ATAIAtai Beckley N.V. | 196,858 | $697K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.